|
|
Pharmacy Information 2024
中药防治脓毒症研究进展
|
Abstract:
脓毒症作为临床常见危重症，在临床仍缺乏非常有效的治疗方法和治疗药物。近年来在中医理论指导及现代药物研究方法的不断更新下，中药在治疗脓毒症方面的研究取得了显著成果。本文分别从单味中药、中药复方汤剂、中成药三个方面研究并总结了中药类药物对脓毒症引起的相关损害的治疗效果，为脓毒症临床治疗提供新思路。
As a common clinical critical illness, sepsis still lacks very effective treatment methods and thera-peutic drugs in the clinic. In recent years, under the guidance of Chinese medicine theory and the continuous updating of modern drug research methods, the research of Chinese medicine in the treatment of sepsis has achieved remarkable results. In this paper, the therapeutic effects of Chi-nese medicines on the related damages caused by sepsis were studied and summarized from three aspects, namely, single-flavored Chinese medicines, Chinese medicines compound soup, and pro-prietary Chinese medicines, which provide new ideas for the clinical treatment of sepsis.
| [1] | Perner, A., Cecconi, M., Cronhjort, M., et al. (2018) Expert Statement for the Management of Hypovolemia in Sepsis. Intensive Care Medicine, 44, 791-798. https://doi.org/10.1007/s00134-018-5177-x |
| [2] | Lei, S., Li, X., Li, J., et al. (2022) Prevalence of Sepsis among Adults in China: A Systematic Review and Meta-Analysis. Frontiers in Public Health, 10, Article ID: 977094. https://doi.org/10.3389/fpubh.2022.977094 |
| [3] | 曾宪斌. 脓毒症患者病原菌分布及耐药性分析[J]. 北方药学, 2019, 16(11): 177-178. |
| [4] | Yang, R. and Zhang, X.J. (2022) A Potential New Path-way for Heparin Treatment of Sepsis-Induced Lung Injury: Inhibition of Pulmonary Endothelial Cell Pyroptosis by Blocking hMGB1-LPS-Induced Caspase-11 Activation. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 984835. https://doi.org/10.3389/fcimb.2022.984835 |
| [5] | Salami, O.M., Habimana, O., Peng, J.F. and Yi, G.H. (2022) Therapeutic Strategies Targeting Mitochondrial Dysfunction in Sepsis-Induced Cardiomyopathy. Cardiovascular Drugs and Therapy.
https://doi.org/10.1007/s10557-022-07354-8 |
| [6] | Balkrishna, A., Sinha, S., Kumar, A., et al. (2023) Sep-sis-Mediated Renal Dysfunction: Pathophysiology, Biomarkers and Role of Phytoconstituents in Its Management. Bio-medicine & Pharmacotherapy, 165, Article ID: 115183.
https://doi.org/10.1016/j.biopha.2023.115183 |
| [7] | Peerapornratana, S., Manrique-caballero, C.L., Gómez, H., et al. (2019) Acute Kidney Injury from Sepsis: Current Concepts, Epidemiology, Pathophysiology, Prevention and Treatment. Kidney International, 96, 1083-1099.
https://doi.org/10.1016/j.kint.2019.05.026 |
| [8] | 王巧玲, 顾乐怡, 戴慧莉. 细胞能量代谢障碍与急性肾小管上皮细胞损伤[J]. 中国中西医结合肾病杂志, 2018, 19(8): 738-740. |
| [9] | Geng, F., Liu, W. and Yu, L. (2022) Mi-croRNA-451a and Th1/Th2 Ratio Inform Inflammation, Septic Organ Injury, and Mortality Risk in Sepsis Patients. Frontiers in Microbiology, 13, Article ID: 947139.
https://doi.org/10.3389/fmicb.2022.947139 |
| [10] | 王慧, 龚园其, 周仪华, 等. 青藤碱调控Nrf2/Keap1信号通路对脓毒症急性肺损伤的改善作用[J]. 实用医学杂志, 2022, 38(15): 1896-1900. |
| [11] | 段金旗, 林艳. 姜黄素对脓毒症急性肺损伤大鼠的保护作用[J]. 中国免疫学杂志, 2020, 36(19): 2380-2383+2388. |
| [12] | 董伟. 大黄调控mTOR/HIF-1a/VEGF信号通路治疗急性肺损伤的机制研究[D]: [硕士学位论文]. 上海: 上海中医药大学, 2019. |
| [13] | 黄有强. 微波辅助提取三叶青多糖工艺优化及其拮抗炎症细胞的研究[J] 浙江中医杂志, 2017, 52(5): 384-385. |
| [14] | 贾合磊, 卢长青, 袁彬, 刘寒阳, 王腾飞. 大黄提取物对脓毒症大鼠急性肾损伤的保护作用和对Keap1/Nrf2信号通路的影响[J]. 药物分析杂志, 2021, 41(6): 979-985. |
| [15] | 朱君瑶, 史忠亮, 郭力恒. 川芎嗪治疗脓毒症的机制研究进展综述[J]. 中国中医急症, 2019, 28(10): 1864-1867. |
| [16] | 王胜超, 曾梦楠, 郑晓珂, 张贝贝, 李本科, 阚玉旋, 冯卫生. 山药中尿囊素干预脓毒症心肌病[J]. 中国新药杂志, 2020, 29(3): 315-322. |
| [17] | Meng, Z.-J., Wang, C., Meng, L.-T., et al. (2018) Sodium Tanshinone IIA Sulfonate Attenuates Cardiac Dysfunction and Im-proves Survival of Rats with Cecal Ligation and Puncture-Induced Sepsis. Chinese Journal of Natural Medicines, 16, 846-855. https://doi.org/10.1016/S1875-5364(18)30126-2 |
| [18] | 孙芳园, 孟佳磊, 马宇慧, 耿欢, 张涛. 川芎嗪对脂多糖诱导大鼠心肌细胞炎症及氧化应激的作用[J]. 中国组织工程研究, 2023, 27(20): 3253-3258. |
| [19] | 任潇潇, 沈晓红, 汪海慧. 炎调方对脓毒症急性肺损伤大鼠肺组织热休克蛋白70mRNA和p38丝裂原活化蛋白激酶的影响[J]. 药物评价研究, 2018, 41(6): 1014-1020. |
| [20] | 易琼, 戴飞跃, 王建湘, 丁灿, 廖杨, 张彬彬, 蔡鹏. 清瘟败毒饮抑制TLR4/NF-κB通路调控小鼠肺泡巨噬细胞自噬减轻脓毒症肺损伤的实验研究[J]. 中国中西医结合杂志, 2023, 43(3): 315-322. |
| [21] | 陈乾, 任潇潇, 韩丹, 施荣, 沈晓红, 熊旭东. 通腑清营汤对脓毒症急性肺损伤大鼠Fas及肿瘤坏死因子-α水平的影响[J]. 中国中医药信息杂志, 2019, 26(12): 40-44. |
| [22] | 黄壑霏, 彭晓洪, 黄亚秀, 陈冬杰, 黄永莲, 王评. 茯苓四逆汤调节TLR-4/NF-κB通道对脓毒症大鼠心肌抑制的保护机制研究[J]. 中医药临床杂志, 2021, 33(9): 1745-1749. |
| [23] | 董颖, 刘保光, 许二平. 黄连解毒汤抗炎作用与临床应用研究进展[J]. 中国实验方剂学杂志, 2021, 27(12): 245-250. |
| [24] | 潘振亚, 王艳鹏, 赵娜, 邓旻. 基于高通量测序探讨参附桃红承气汤对脓毒症大鼠心肌抑制的影响[J]. 中国现代医生, 2022, 60(7): 25-30+197. |
| [25] | 聂莎, 廖杨, 张彬彬, 等. 补中益气联合大承气汤治疗脓毒症胃肠功能障碍气虚腑实证临床观察[J]. 亚太传统医 药, 2022, 18(2): 108-113. |
| [26] | Wu, J.S., Luo, Y., Deng, D.H., Su, S.Y. and Li, S. (2019) Coptisine from Coptis chinensis Exerts Di-verse Beneficial Properties: A Concise Review. Journal of Cellular and Molecular Medicine, 23, 7946-7960.
https://doi.org/10.1111/jcmm.14725 |
| [27] | Xu, P., Zhang, W.-Q., Xie, J., Wen, Y.-S., Zhang, G.-X. and Lu, S.-Q. (2020) Shenfu Injection Prevents Sepsis-Induced Myocardial Injury by Inhibiting Mitochondrial Apoptosis. Journal of Ethnopharmacology, 261, Article ID: 113068. https://doi.org/10.1016/j.jep.2020.113068 |
| [28] | Shi, X., Chen, G.N., Wei, J., Feng, D. and Chen, Y.L. (2018) UHPLC-Q-TOF MS-Based Metabolic Analysis for the Therapeutic Efficacy of “Xuebijing Injection” against Sepsis-Induced Acute Lung Injury. Evidence-Based Complementary and Alternative Medi-cine: eCAM, 2018, Article ID: 8514619. https://doi.org/10.1155/2018/8514619 |
| [29] | Wang, X.T., Peng, Z., An, Y.Y., Shang, T., Xiao, G.X., et al. (2021) Paeoniflorin and Hydroxysafflor Yellow A in Xuebijing Injection Attenuate Sepsis-Induced Cardiac Dysfunction and Inhibit Proinflammatory Cytokine Production. Frontiers in Pharmacology, 11, Article ID: 614024. https://doi.org/10.3389/fphar.2020.614024 |
| [30] | 潘雪薇, 薛漓轩, 张佳智, 代玉洁, 李芳, 张媛媛, 寇俊萍. 注射用益气复脉(冻干)对脓毒症诱导小鼠急性肺损伤的改善作用研究[J]. 中国中医急症, 2021, 30(7): 1129-1133+1168. |
| [31] | 巫莉萍, 薛小燕, 温建东. 参苓白术颗粒对脓毒症大鼠的保护作用及对肺水代谢的影响[J]. 中国医学创新, 2020, 17(34): 26-29. |
| [32] | 梁志奇, 吴晖, 何卫东, 邵丹. 康达心口服液治疗脓毒症心肌损伤的临床观察[J]. 亚太传统医药, 2018, 14(5): 180-182. |
| [33] | 狄浩然, 王晓鹏, 梁立新, 卢幼然, 郭玉红, 段美丽, 刘清泉. 芪归银颗粒治疗脓毒症急性肾损伤患者的临床研究[J]. 中国中医急症, 2021, 30(9): 1583-1585+1606. |
| [34] | 高博文. 公英二子汤对脂多糖诱导脓毒症急性肾损伤模型大鼠的保护作用及机制研究[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2019. |
| [35] | 梁志奇, 吴晖, 叶妍婕, 等. 犀角地黄汤对脓毒症凝血功能障碍患者凝血指标和临床疗效的影响[J]. 当代医学, 2021, 27(25): 136-137. |
| [36] | Chen, Z.J., Liu, L.J., Gao, C.F., et al. (2020) Astragali Radix (Huangqi): A Promising Edible Immunomodulatory Herbal Medicine. Journal of Ethnopharmacology, 258, Article 112895. https://doi.org/10.1016/j.jep.2020.112895 |
| [37] | 阮俊, 王利粉, 徐慕娟. 黄芪注射液辅助治疗脓毒症患者的效果及对其免疫细胞、细胞因子水平的影响[J]. 实用中医内科杂志, 2021, 35(8): 66-68. |
